(Q36779656)

16 August 2017

1 reference

title

Serotonin reuptake inhibitor-induced perinatal complications (English)

1 reference

16 August 2017

Salvatore Gentile

1

0 references

publication date

1 January 2007

1 reference

16 August 2017

1 reference

16 August 2017

volume

9

1 reference

16 August 2017

issue

2

1 reference

16 August 2017

page(s)

97-106

1 reference

Implications of antenatal depression and anxiety for obstetric outcome.

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F00148581-200709020-00003

Perinatal outcome following third trimester exposure to paroxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00148581-200709020-00003

Can venlafaxine in breast milk attenuate the norepinephrine and serotonin reuptake neonatal withdrawal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00148581-200709020-00003

The impact of depression and fluoxetine treatment on obstetrical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00148581-200709020-00003

Risks associated with selective serotonin reuptake inhibitors in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00148581-200709020-00003

Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00148581-200709020-00003

The role of estrogen therapy in postpartum psychiatric disorders: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00148581-200709020-00003

Neonatal convulsions and subarachnoid hemorrhage after in utero exposure to paroxetine

21 January 2018

1 reference

12 December 2020

Birth outcomes after prenatal exposure to antidepressant medication

1 reference

12 December 2020

Use of psychoactive medication during pregnancy and possible effects on the fetus and newborn. Committee on Drugs. American Academy of Pediatrics

1 reference

12 December 2020

Antidepressants in amniotic fluid: another route of fetal exposure.

1 reference

12 December 2020

Pain reactivity in 2-month-old infants after prenatal and postnatal serotonin reuptake inhibitor medication exposure.

1 reference

12 December 2020

Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors

1 reference

12 December 2020

Primary pulmonary hypertension

1 reference

12 December 2020

Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates

1 reference

12 December 2020

Fluoxetine (Prozac) as a cause of QT prolongation

1 reference

12 December 2020

Prevalence of mood symptoms and depressions during pregnancy: implications for clinical practice and research

1 reference

12 December 2020

Externalizing and attentional behaviors in children of depressed mothers treated with a selective serotonin reuptake inhibitor antidepressant during pregnancy

1 reference

12 December 2020

Phototherapy-mediated syndrome of inappropriate secretion of antidiuretic hormone in an in utero selective serotonin reuptake inhibitor-exposed newborn infant.

1 reference

12 December 2020

Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants

1 reference

12 December 2020

Cardiac arrhythmia in a newborn infant associated with fluoxetine use during pregnancy

1 reference

12 December 2020

Neonatal symptoms following maternal paroxetine treatment: serotonin toxicity or paroxetine discontinuation syndrome?

1 reference

12 December 2020

Prolonged QT interval in an infant of a fluoxetine treated mother

1 reference

12 December 2020

Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.

1 reference

12 December 2020

Prophylactic treatment of bipolar disorder in pregnancy and breastfeeding: focus on emerging mood stabilizers

1 reference

12 December 2020

Fluoxetine hydrochloride (Prozac) toxicity in a neonate

1 reference

12 December 2020

Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn.

1 reference

12 December 2020

Perinatal risks of untreated depression during pregnancy

1 reference

12 December 2020

SSRIs in pregnancy and lactation: emphasis on neurodevelopmental outcome

1 reference

12 December 2020

The safety of newer antidepressants in pregnancy and breastfeeding

1 reference

12 December 2020

A pilot study of newer antidepressant concentrations in cord and maternal serum and possible effects in the neonate

1 reference

12 December 2020

Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and effects on the fetus and newborn: a meta-analysis.

1 reference

12 December 2020

Paroxetine toxicity in a newborn after in utero exposure: clinical symptoms correlate with serum levels

1 reference

12 December 2020

Neonatal intraventricular haemorrhage associated with maternal use of paroxetine

1 reference

12 December 2020

Is the serotonin transporter involved in the pathogenesis of pulmonary hypertension?

1 reference

12 December 2020

Analysis of responses to serotonin in the pulmonary vascular bed of the cat

1 reference

12 December 2020

Platelet serotonin in newborns and infants: ontogeny, heritability, and effect of in utero exposure to selective serotonin reuptake inhibitors

1 reference

12 December 2020

Severe adverse effects in a newborn with two defective CYP2D6 alleles after exposure to paroxetine during late pregnancy

1 reference

12 December 2020

Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications

1 reference

12 December 2020

Neonatal paroxetine withdrawal syndrome

1 reference

12 December 2020

Internalizing behaviors in 4-year-old children exposed in utero to psychotropic medications

1 reference

12 December 2020

Birth outcomes in pregnant women taking fluoxetine

1 reference

12 December 2020

Case report of a syncopal episode associated with fluoxetine

1 reference

12 December 2020

Effects of third trimester fluoxetine exposure on the newborn

1 reference

12 December 2020

Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment.

1 reference

12 December 2020

Fluoxetine withdrawal syndrome in the newborn.

1 reference

12 December 2020

Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations

1 reference

12 December 2020

[Neonatal withdrawal syndrome to selective serotonin reuptake inhibitors: case report and literature review]

1 reference

12 December 2020

Outcomes of prenatal antidepressant exposure

1 reference

12 December 2020

Paroxetine withdrawal syndrome as differential diagnosis of acute neonatal encephalopathy?

1 reference

12 December 2020

Withdrawal symptoms in a neonate following exposure to venlafaxine during pregnancy

1 reference

12 December 2020

Withdrawal reactions of a premature neonate after maternal use of paroxetine

1 reference

12 December 2020

Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy

1 reference

12 December 2020

Paroxetine withdrawal syndrome in a neonate

1 reference

12 December 2020

Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data

1 reference

12 December 2020

Prevalence of psychiatric disorders in gynecologic outpatients

1 reference

12 December 2020

Escitalopram Late in Pregnancy and While Breast-Feeding

1 reference

12 December 2020

Neonatal seizures from in utero venlafaxine exposure

1 reference

12 December 2020

Citalopram in pregnancy and lactation

1 reference

12 December 2020

Paroxetine use throughout pregnancy: does it pose any risk to the neonate?

1 reference

12 December 2020

Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior

1 reference

12 December 2020

A screening study of antidepressant treatment rates and mood symptoms in pregnancy

1 reference

12 December 2020

Citalopram use in pregnancy: prospective comparative evaluation of pregnancy and fetal outcome

1 reference

12 December 2020

10.2165/00148581-200709020-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

16 August 2017

1002976145

0 references

Fatcat ID

release_rcaux53f4jhebaadr5aebkouhy

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rcaux53f4jhebaadr5aebkouhy

24 November 2022

mapped directly with Wikidata item

1 reference